SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR
申请人:Boehringer Ingelheim International GmbH
公开号:EP2595959B1
公开(公告)日:2015-11-04
US8846936B2
申请人:——
公开号:US8846936B2
公开(公告)日:2014-09-30
[EN] SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECE<br/>[FR] COMPOSÉS SULFONYLÉS QUI MODULENT LE RÉCEPTEUR CB2
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2012012307A1
公开(公告)日:2012-01-26
Compounds of formula (I) and formula (II) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
[EN] SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR<br/>[FR] COMPOSÉS SULFONYLÉS QUI MODULENT LE RÉCEPTEUR CB2